documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
58 rows where docket_id = "FDA-2023-N-3392" and posted_year = 2023 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-3392-0019 | FDA | None FDA-2023-N-3392 | Reference 17 - Hutchings M., A. Truman, and B. Wilkinson, “Antibiotics: Past, Present and Future,” Current Opinion in Microbiology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:08:14Z | 0 | 0 | 090000648630c910 | |||
| FDA-2023-N-3392-0035 | FDA | None FDA-2023-N-3392 | Reference 33 - Leonel C., I. Sena, W. Silva, et al., “Staphylococcus Epidermidis Role in the Skin Microenvironment,” Journal of Cellular And Molecular Medicine | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:13:08Z | 0 | 0 | 090000648630cbac | |||
| FDA-2023-N-3392-0005 | FDA | None FDA-2023-N-3392 | Reference 3 - General and Plastic Surgery Devices Panel, “2016 Meeting Materials of the General and Plastic Surgery Advisory Panel--September 20-21, 2016” | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:04:06Z | 0 | 0 | 090000648630c213 | |||
| FDA-2023-N-3392-0007 | FDA | None FDA-2023-N-3392 | Reference 5 - Sen C., G. Gordillo, S. Roy, et al., “Human Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy,” Wound Repair and Regeneration | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:04:40Z | 0 | 0 | 090000648630c215 | |||
| FDA-2023-N-3392-0012 | FDA | None FDA-2023-N-3392 | Reference 10 - Hess C.T., “Putting the Squeeze on Venous Ulcers,” Nursing | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:06:00Z | 0 | 0 | 090000648630c368 | |||
| FDA-2023-N-3392-0016 | FDA | None FDA-2023-N-3392 | Reference 14 - Gottrup F., J. Apelqvist, T. Bjarnsholt, et al., “Antimicrobials and Non-Healing Wounds: Evidence, Controversies, and Suggestions--Key Messages,” Journal of Wound Care | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:07:06Z | 0 | 0 | 090000648630c439 | |||
| FDA-2023-N-3392-0020 | FDA | None FDA-2023-N-3392 | Reference 18 - CDC, Antibiotic Resistance Threats in the United States 2019 Report | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:08:26Z | 0 | 0 | 090000648630c913 | |||
| FDA-2023-N-3392-0031 | FDA | None FDA-2023-N-3392 | Reference 29 - Government of Canada, “Categorization of Antimicrobial Drugs Based on Importance in Human Medicine,” 2009 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:12:01Z | 0 | 0 | 090000648630ca93 | |||
| FDA-2023-N-3392-0004 | FDA | None FDA-2023-N-3392 | Reference 2 - General and Plastic Surgery Devices Panel, “Brief Summary from the General and Plastic Surgery Devices Panel Meeting--August 25-26, 2005” | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:03:43Z | 0 | 0 | 090000648630bc20 | |||
| FDA-2023-N-3392-0025 | FDA | None FDA-2023-N-3392 | Reference 23 - Munita J. and C. Arias, “Mechanisms of Antibiotic Resistance,” Microbiology Spectrum | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:10:16Z | 0 | 0 | 090000648630c9ee | |||
| FDA-2023-N-3392-0039 | FDA | None FDA-2023-N-3392 | Reference 37 - Burke T., M. Rupp, P. Fey, “Staphylococcus Epidermidis,” Trends in Microbiology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:14:23Z | 0 | 0 | 090000648630cbb0 | |||
| FDA-2023-N-3392-0013 | FDA | None FDA-2023-N-3392 | Reference 11 - Driver V., M. Fabbi, L. Lavery, et al., “The Costs of Diabetic Foot: The Economic Case for the Limb Salvage Team,” Journal of Vascular Surgery | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:06:18Z | 0 | 0 | 090000648630c36d | |||
| FDA-2023-N-3392-0043 | FDA | None FDA-2023-N-3392 | Reference 41 - Choi Y., K. Campbell, C. Levek, et al., “Antibiotic Ointment Versus a Silver-Based Dressing for Children With Extremity Burns: A Randomized Controlled Study,” Journal of Pediatric Surgery | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:15:30Z | 0 | 0 | 090000648630cc34 | |||
| FDA-2023-N-3392-0055 | FDA | None FDA-2023-N-3392 | Reference 53 - Luqman A., M. Muttaqin, S. Yulaipi, et al., “Trace Amines Produced by Skin Bacteria Accelerate Wound Healing in Mice,” Communications Biology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:19:29Z | 0 | 0 | 090000648630d2a9 | |||
| FDA-2023-N-3392-0021 | FDA | None FDA-2023-N-3392 | Reference 19 - Dadgostar P., “Antimicrobial Resistance: Implications and Costs.,” Infection and Drug Resistance | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:09:03Z | 0 | 0 | 090000648630c915 | |||
| FDA-2023-N-3392-0048 | FDA | None FDA-2023-N-3392 | Reference 46 - Serena T., L. Serena, O. Al-Jalodi, et al., “The Efficacy of Sodium Hypochlorite Antiseptic: A Double-Blind, Randomised Controlled Pilot Study,” Journal of Wound Care | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:17:11Z | 0 | 0 | 090000648630d115 | |||
| FDA-2023-N-3392-0049 | FDA | None FDA-2023-N-3392 | Reference 47 - Saad A., E. Salazar, L. Allen, et al., “Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Randomized Controlled Trial,” American Journal of Perinatology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:17:20Z | 0 | 0 | 090000648630d116 | |||
| FDA-2023-N-3392-0051 | FDA | None FDA-2023-N-3392 | Reference 49 - Linehanm J., O. Harrison, S. Han, et al., “Non-Classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair,” Cell | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:17:57Z | 0 | 0 | 090000648630d119 | |||
| FDA-2023-N-3392-0053 | FDA | None FDA-2023-N-3392 | Reference 51 - Leonel C., I. Sena, W. Silva, et al., “Staphylococcus Epidermidis Role in the Skin Microenvironment,” Journal of Cellular and Molecular Medicine | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:18:33Z | 0 | 0 | 090000648630d2a3 | |||
| FDA-2023-N-3392-0040 | FDA | None FDA-2023-N-3392 | Reference 38 - FDA, “Classification of Products as Drugs and Devices & Additional Product Classification Issues: Guidance for Industry and FDA Staff,” September 2017 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:14:36Z | 0 | 0 | 090000648630cc31 | |||
| FDA-2023-N-3392-0015 | FDA | None FDA-2023-N-3392 | Reference 13 - Guo S. and L.A. DiPietro, “Factors Affecting Wound Healing,” Journal of Dental Research | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:06:53Z | 0 | 0 | 090000648630c435 | |||
| FDA-2023-N-3392-0034 | FDA | None FDA-2023-N-3392 | Reference 32 - Johnson T., B. Gomez, M. McIntyre, et al., “The Cutaneous Microbiome and Wounds: New Molecular Targets To Promote Wound Healing,” International Journal of Molecular Sciences | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:12:58Z | 0 | 0 | 090000648630ca9b | |||
| FDA-2023-N-3392-0041 | FDA | None FDA-2023-N-3392 | Reference 39 - FDA, “General and Plastic Surgery Devices; Classification of the Nonresorbable Gauze/Sponge for External Use, the Hydrophilic Wound Dressing, the Occlusive Wound Dressing, and the Hydrogel Wound Dressing,” 64 FR 53927, October 5, 1999 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:15:05Z | 0 | 0 | 090000648630cc32 | |||
| FDA-2023-N-3392-0003 | FDA | None FDA-2023-N-3392 | Reference 1 - General and Plastic Surgery Devices Panel, “Transcript of the FDA General and Plastic Surgery Devices Panel meeting - November 17, 1998" | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:03:11Z | 0 | 0 | 090000648630bc1f | |||
| FDA-2023-N-3392-0002 | FDA | None FDA-2023-N-3392 | List of References | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:02:58Z | 0 | 0 | 090000648630bc1c | |||
| FDA-2023-N-3392-0006 | FDA | None FDA-2023-N-3392 | Reference 4 - WHO, “Critically Important Antimicrobials For Human Medicine: 6th Revision” | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:04:24Z | 0 | 0 | 090000648630c214 | |||
| FDA-2023-N-3392-0008 | FDA | None FDA-2023-N-3392 | Reference 6 - Nussbaum S., M. Carter, C. Fife, et al., “An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds,” Value in Health | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:05:02Z | 0 | 0 | 090000648630c217 | |||
| FDA-2023-N-3392-0037 | FDA | None FDA-2023-N-3392 | Reference 35 - Luqman A., M. Muttaqin, S. Yulaipi, et al., “Trace Amines Produced by Skin Bacteria Accelerate Wound Healing in Mice,” Communications Biology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:13:47Z | 0 | 0 | 090000648630cbae | |||
| FDA-2023-N-3392-0038 | FDA | None FDA-2023-N-3392 | Reference 36- Brown M., A. Horswill, “Staphylococcus Epidermidis--Skin Friend or Foe?” PLOS Pathogens | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:14:13Z | 0 | 0 | 090000648630cbaf | |||
| FDA-2023-N-3392-0028 | FDA | None FDA-2023-N-3392 | Reference 26 - Peleg A., and D. Hooper. “Hospital-Acquired Infections Due to Gram-Negative Bacteria,” The New England Journal of Medicine | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:11:13Z | 0 | 0 | 090000648630c9f5 | |||
| FDA-2023-N-3392-0030 | FDA | None FDA-2023-N-3392 | Reference 28 - FDA, “Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern: Guidance for Industry,” October 23, 2003 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:11:37Z | 0 | 0 | 090000648630ca92 | |||
| FDA-2023-N-3392-0032 | FDA | None FDA-2023-N-3392 | Reference 30 - McDonnell G., and A. Russell, “Antiseptic and Disinfectants: Activity, Action, and Resistance,” Clinical Microbiology Reviews | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:12:10Z | 0 | 0 | 090000648630ca95 | |||
| FDA-2023-N-3392-0042 | FDA | None FDA-2023-N-3392 | Reference 40 - FDA, “Medical Devices; Plastic Surgery Devices; Classification of Wound Dressing With Poly (Diallyl Dimethyl Ammonium Chloride) Additive,” 74 FR 53165, October 16, 2009 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:15:20Z | 0 | 0 | 090000648630cc33 | |||
| FDA-2023-N-3392-0045 | FDA | None FDA-2023-N-3392 | Reference 43 - Kim D., W. Namen Ii, J. Moore, et al., “Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach,” Wounds | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:16:12Z | 0 | 0 | 090000648630cc36 | |||
| FDA-2023-N-3392-0057 | FDA | None FDA-2023-N-3392 | Reference 55 - Burke T., M. Rupp, P. Fey, “Staphylococcus Epidermidis,” Trends in Microbiology, 2023 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:19:47Z | 0 | 0 | 090000648630d2c4 | |||
| FDA-2023-N-3392-0058 | FDA | None FDA-2023-N-3392 | Reference 56 - FDA’s Full Preliminary Analysis of Economic Impacts | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:20:10Z | 0 | 0 | 090000648630d2c5 | |||
| FDA-2023-N-3392-0014 | FDA | None FDA-2023-N-3392 | Reference 12 - Gordon M., M. Gottschlich, E. Helvig, et al., “Review of Evidence-Based Practice for the Prevention of Pressure Sores in Burn Patients,” Journal of Burn Care & Research | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:06:41Z | 0 | 0 | 090000648630c434 | |||
| FDA-2023-N-3392-0022 | FDA | None FDA-2023-N-3392 | Reference 20 - National Quality Forum, “NQF, CDC Issue Guidance To Help Hospitals Better Manage Use of Antibiotics,” 2016 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:09:13Z | 0 | 0 | 090000648630c916 | |||
| FDA-2023-N-3392-0024 | FDA | None FDA-2023-N-3392 | Reference 22 - HHS, “Antimicrobial Resistance” | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:10:03Z | 0 | 0 | 090000648630c9ed | |||
| FDA-2023-N-3392-0029 | FDA | None FDA-2023-N-3392 | Reference 27 - WHO, “Burns” | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:11:24Z | 0 | 0 | 090000648630c9f6 | |||
| FDA-2023-N-3392-0011 | FDA | None FDA-2023-N-3392 | Reference 9 - Kuhn A., S.J. Coulter, “Balancing Ulcer Cost and Quality Equation,” Nursing Economics | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:05:50Z | 0 | 0 | 090000648630c21a | |||
| FDA-2023-N-3392-0023 | FDA | None FDA-2023-N-3392 | Reference 21 - CDC, The Core Elements of Hospital Antibiotic Stewardship Programs: 2019 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:09:32Z | 0 | 0 | 090000648630c919 | |||
| FDA-2023-N-3392-0036 | FDA | None FDA-2023-N-3392 | Reference 34 - Pastar I., K. O’Neill, L. Padula, et al., “Staphylococcus Epidermidis Boosts Innate Immune Response by Activation of Gamma Delta T Cells and Induction of Perforin-2 in Human Skin,” Frontiers in Immunology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:13:37Z | 0 | 0 | 090000648630cbad | |||
| FDA-2023-N-3392-0010 | FDA | None FDA-2023-N-3392 | Reference 8 - Carter M., C. Fife, D. Walker, et al., “Estimating the Applicability of Wound Care Randomized Controlled Trials to General Wound-Care Populations by Estimating the Percentage of Individuals Excluded from a Typical Wound-Care Population in Such Trials,” Advances in Skin & Wound Care | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:05:26Z | 0 | 0 | 090000648630c219 | |||
| FDA-2023-N-3392-0046 | FDA | None FDA-2023-N-3392 | Reference 44 - Connery S., J. Yankowitz, L. Odibo, et al., “Effect of Using Silver Nylon Dressings To Prevent Superficial Surgical Site Infection After Cesarean Delivery: A Randomized Clinical Trial,” American Journal of Obstetrics and Gynecology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:16:21Z | 0 | 0 | 090000648630cc37 | |||
| FDA-2023-N-3392-0050 | FDA | None FDA-2023-N-3392 | Reference 48 - Dissemond J., J. Steinmann, K. Münter, et al., “Risk and Clinical Impact of Bacterial Resistance/Susceptibility to Silver-Based Wound Dressings: A Systematic Review,” Journal of Wound Care | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:17:30Z | 0 | 0 | 090000648630d117 | |||
| FDA-2023-N-3392-0052 | FDA | None FDA-2023-N-3392 | Reference 50 - Johnson T., B. Gomez, M. McIntyre, et al., “The Cutaneous Microbiome and Wounds: New Molecular Targets To Promote Wound Healing,” International Journal of Molecular Science | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:18:23Z | 0 | 0 | 090000648630d11a | |||
| FDA-2023-N-3392-0026 | FDA | None FDA-2023-N-3392 | Reference 24 - Bennett, P.M., “Plasmid Encoded Antibiotic Resistance: Acquisition and Transfer of Antibiotic Resistance Genes in Bacteria,” British Journal of Pharmacology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:10:27Z | 0 | 0 | 090000648630c9ef | |||
| FDA-2023-N-3392-0044 | FDA | None FDA-2023-N-3392 | Reference 42 - Benedetto A., J. Staidle, J. Schoenfeld, et al., “Comparing the Use of a Novel Antibiotic-Free Film-Forming Topical Wound Dressing Versus a Topical Triple Antibiotic in Dermatologic Surgical Procedures Including Mohs Micrographic Surgery,” Journal of European Academy of Dermatology and Venereology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:16:02Z | 0 | 0 | 090000648630cc35 | |||
| FDA-2023-N-3392-0056 | FDA | None FDA-2023-N-3392 | Reference 54 - Brown M., A. Horswill, “Staphylococcus Epidermidis--Skin Friend or Foe?” PLOS Pathogens | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:19:37Z | 0 | 0 | 090000648630d2aa | |||
| FDA-2023-N-3392-0017 | FDA | None FDA-2023-N-3392 | Reference 15 - Sen, C., “Human Wounds and Its Burden: An Updated Compendium of Estimates,” Advances in Wound Care | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:07:26Z | 0 | 0 | 090000648630c43a | |||
| FDA-2023-N-3392-0027 | FDA | None FDA-2023-N-3392 | Reference 25 - Chandan P., J. Bengtsson-Palme, E. Kristiansson, et al., “Co-Occurrence of Resistance Genes to Antibiotics, Biocides and Metals Reveals Novel Insights into Their Co-Selection Potential,” BMC Genomics | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:10:36Z | 0 | 0 | 090000648630c9f2 | |||
| FDA-2023-N-3392-0018 | FDA | None FDA-2023-N-3392 | Reference 16 - FDA, “Supporting Antimicrobial Stewardship in Veterinary Settings: Goals for Fiscal Years 2024-2028: Key Phase 3 and Key Phase 4 Actions,” September 2023 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:07:37Z | 0 | 0 | 090000648630c43b | |||
| FDA-2023-N-3392-0047 | FDA | None FDA-2023-N-3392 | Reference 45 - Ahmad H., K. Kallies, and S. Shapiro, “The Effect of Mupirocin Dressings on Postoperative Surgical Site Infections in Elective Colorectal Surgery: A Prospective, Randomized Controlled Trial,” The American Journal of Surgery | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:16:31Z | 0 | 0 | 090000648630d114 | |||
| FDA-2023-N-3392-0054 | FDA | None FDA-2023-N-3392 | Reference 52 - Pastar I., K. O’Neill, L. Padula, et al., “Staphylococcus Epidermidis Boosts Innate Immune Response by Activation of Gamma Delta T Cells and Induction of Perforin-2 in Human Skin,” Frontiers in Immunology | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:18:42Z | 0 | 0 | 090000648630d2a7 | |||
| FDA-2023-N-3392-0009 | FDA | None FDA-2023-N-3392 | Reference 7 - Berry C., D.R. Murdoch, and J.J. McMurray, “Economics of Chronic Heart Failure,” European Journal of Heart Failure | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:05:14Z | 0 | 0 | 090000648630c218 | |||
| FDA-2023-N-3392-0033 | FDA | None FDA-2023-N-3392 | Reference 31 - Linehanm J., O. Harrison, S. Han, et al., “Non-Classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair,” Cell | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:12:22Z | 0 | 0 | 090000648630ca98 | |||
| FDA-2023-N-3392-0001 | FDA | None FDA-2023-N-3392 | Medical Devices; General and Plastic Surgery Devices; Classification of Certain Solid Wound Dressings; Wound Dressings Formulated as a Gel, Creams, or Ointment; and Liquid Wound Washes | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2023-11-30T05:00:00Z | 2023 | 11 | 2023-11-30T05:00:00Z | 2024-02-29T04:59:59Z | 2024-03-19T01:03:58Z | 2023-26209 | 0 | 0 | 09000064862c31a9 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;